Biography/Memoir

FDA withdraws request for White House permission to study kratom and psychedelics risks amid criticism

[Friday, August 9, 2024] “…it is time for Commissioner [Robert] Califf to exercise direct oversight and order the Agency [FDA] to reassess its biased attacks on kratom and psychedelics,” Mac Haddow, senior fellow of public policy for American Kratom Association…

August 12, 2024; The Food and Drug Administration (FDA) has withdrawn a request for White House permission to conduct a study about the risks of using kratom and psychedelics amid a “rapid resurgence” of public interest in the substances. Advocates are celebrating the news after criticizing the initial request as another example of FDA “bias” against harm reduction options…

Original Article (Marijuana Moment):
FDA withdraws request for White House permission to study kratom and psychedelics risks amid criticism
Artwork Fair Use: Public domain

Biography/Memoir

Patented…

Biography/Memoir

…launch of…